139 related articles for article (PubMed ID: 16914593)
41. Changes of lacrimal gland and tear inflammatory cytokines in thyroid-associated ophthalmopathy.
Huang D; Luo Q; Yang H; Mao Y
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4935-43. PubMed ID: 24994866
[TBL] [Abstract][Full Text] [Related]
42. Wnt signalling inhibits adipogenesis in orbital fibroblasts from patients with Graves' orbitopathy.
Jung SJ; Choi YJ; Park TK; Woo SE; Kim BY; Yoon JS; Jang SY
Br J Ophthalmol; 2022 Jul; 106(7):1019-1027. PubMed ID: 34193409
[TBL] [Abstract][Full Text] [Related]
43. Prostaglandin F2α Regulates Adipogenesis by Modulating Extracellular Signal-Regulated Kinase Signaling in Graves' Ophthalmopathy.
Zhu R; Wang XH; Wang BW; Ouyang X; You YY; Xie HT; Zhang MC; Jiang FG
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108173
[TBL] [Abstract][Full Text] [Related]
44. [Effects of interleukin on orbital fibroblasts of patients with Graves' ophthalmopathy].
Zhang XJ; Luo QL; Zhang MX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):241-3. PubMed ID: 15071929
[TBL] [Abstract][Full Text] [Related]
45. Possible targets for nonimmunosuppressive therapy of Graves' orbitopathy.
Zhang L; Grennan-Jones F; Draman MS; Lane C; Morris D; Dayan CM; Tee AR; Ludgate M
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1183-90. PubMed ID: 24758182
[TBL] [Abstract][Full Text] [Related]
46. Lutein targeting orbital fibroblasts attenuates fibrotic and inflammatory effects in thyroid-associated ophthalmopathy.
Hei X; Lin B; Wu P; Li X; Mao Z; Huang S; Zhang F; Zhou M; Ke Y; Yang H; Huang D
Exp Eye Res; 2023 Jul; 232():109515. PubMed ID: 37207866
[TBL] [Abstract][Full Text] [Related]
47. Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid-associated ophthalmopathy.
Metcalfe RA; Weetman AP
Clin Endocrinol (Oxf); 1994 Jan; 40(1):67-72. PubMed ID: 8306483
[TBL] [Abstract][Full Text] [Related]
48. PDK2-enhanced glycolysis promotes fibroblast proliferation in thyroid-associated ophthalmopathy.
Ma R; Gan L; Ren H; Harrison A; Qian J
J Mol Endocrinol; 2020 Nov; 65(4):163-174. PubMed ID: 33086191
[TBL] [Abstract][Full Text] [Related]
49. RNA-Sequencing Gene Expression Profiling of Orbital Adipose-Derived Stem Cell Population Implicate HOX Genes and WNT Signaling Dysregulation in the Pathogenesis of Thyroid-Associated Orbitopathy.
Tao W; Ayala-Haedo JA; Field MG; Pelaez D; Wester ST
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6146-6158. PubMed ID: 29214313
[TBL] [Abstract][Full Text] [Related]
50. Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves' orbitopathy.
Zhang L; Grennan-Jones F; Lane C; Rees DA; Dayan CM; Ludgate M
J Clin Endocrinol Metab; 2012 Feb; 97(2):653-62. PubMed ID: 22162480
[TBL] [Abstract][Full Text] [Related]
51. PH20 Inhibits TGFβ1-Induced Differentiation of Perimysial Orbital Fibroblasts via Hyaluronan-CD44 Pathway in Thyroid-Associated Ophthalmopathy.
Ma R; Ren H; Xu B; Cheng Y; Gan L; Zhang R; Wu J; Qian J
Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1431-1441. PubMed ID: 30947333
[TBL] [Abstract][Full Text] [Related]
52. Reversal of Pathological Features of Graves' Orbitopathy by Activation of Forkhead Transcription Factors, FOXOs.
Zhang L; Ji QH; Ruge F; Lane C; Morris D; Tee AR; Dayan CM; Ludgate M
J Clin Endocrinol Metab; 2016 Jan; 101(1):114-22. PubMed ID: 26502358
[TBL] [Abstract][Full Text] [Related]
53. Tim3/galectin-9 alleviates the inflammation of TAO patients via suppressing Akt/NF-kB signaling pathway.
Luo LH; Li DM; Wang YL; Wang K; Gao LX; Li S; Yang JG; Li CL; Feng W; Guo H
Biochem Biophys Res Commun; 2017 Sep; 491(4):966-972. PubMed ID: 28756232
[TBL] [Abstract][Full Text] [Related]
54. Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone.
Antonelli A; Ferrari SM; Fallahi P; Piaggi S; Paolicchi A; Franceschini SS; Salvi M; Ferrannini E
Metabolism; 2011 Feb; 60(2):277-83. PubMed ID: 20206950
[TBL] [Abstract][Full Text] [Related]
55. The Role of Sphingosine-1-Phosphate in Adipogenesis of Graves' Orbitopathy.
Kim SE; Lee JH; Chae MK; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):301-11. PubMed ID: 26830367
[TBL] [Abstract][Full Text] [Related]
56. CD34- Orbital Fibroblasts From Patients With Thyroid-Associated Ophthalmopathy Modulate TNF-α Expression in CD34+ Fibroblasts and Fibrocytes.
Lu Y; Atkins SJ; Fernando R; Trierweiler A; Mester T; Grisolia ABD; Mou P; Novaes P; Smith TJ
Invest Ophthalmol Vis Sci; 2018 May; 59(6):2615-2622. PubMed ID: 29847668
[TBL] [Abstract][Full Text] [Related]
57. Beneficial effect of pentoxifylline on thyroid associated ophthalmopathy (TAO)*: a pilot study.
Balazs C; Kiss E; Vamos A; Molnar I; Farid NR
J Clin Endocrinol Metab; 1997 Jun; 82(6):1999-2002. PubMed ID: 9177420
[TBL] [Abstract][Full Text] [Related]
58. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
Dik WA; Virakul S; van Steensel L
Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405
[TBL] [Abstract][Full Text] [Related]
59. Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.
Antonelli A; Ferrari SM; Fallahi P; Frascerra S; Santini E; Franceschini SS; Ferrannini E
J Clin Endocrinol Metab; 2009 May; 94(5):1803-9. PubMed ID: 19276231
[TBL] [Abstract][Full Text] [Related]
60. Thyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis).
Douglas RS; Mester T; Ginter A; Kim DS
Trans Am Ophthalmol Soc; 2014; 112():26-37. PubMed ID: 25411513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
